Market
Fresh lucuma (Pouteria lucuma) is an uncommon specialty fruit in the United States, with domestic supply largely limited to small-scale plantings rather than a clearly documented commercial orchard industry. The U.S. market role for fresh lucuma is therefore best characterized as an import-dependent niche consumer market, with any commercial imports gated by USDA-APHIS admissibility and phytosanitary conditions published in ACIR. Lucuma is listed as a host plant for the Mediterranean fruit fly (Ceratitis capitata), making phytosanitary treatment and inspection requirements a likely binding constraint for fresh-fruit entry. FDA import requirements (e.g., facility registration and prior notice, as applicable) add additional compliance obligations for commercial supply.
Market RoleImport-dependent niche consumer market (fresh lucuma) with limited domestic specialty plantings
Domestic RoleNiche specialty fruit; limited domestic plantings in warm microclimates and collections
Risks
Phytosanitary HighMarket access for fresh lucuma can be blocked or delayed if APHIS admissibility and quarantine pest mitigation requirements are not met; lucuma (Pouteria lucuma) is listed as a host plant for the Mediterranean fruit fly (Ceratitis capitata), a quarantine-significant pest that commonly drives strict phytosanitary measures for fresh fruit pathways.Before sourcing, verify lucuma admissibility and exact commodity/origin conditions in APHIS ACIR; align any required treatment/safeguarding and NPPO certification with the exporting country and logistics plan, and ship only under the stipulated permit/conditions.
Regulatory Compliance MediumIf fresh lucuma from a given origin is not already authorized in ACIR, import may require an APHIS commodity import request and pest risk analysis process, extending timelines and increasing uncertainty for commercial planning.Screen ACIR early; if not authorized, coordinate with the exporting NPPO to initiate the APHIS commodity import approval process and plan for extended lead times.
Food Safety MediumFDA may detain imported food at U.S. ports of entry if shipments are not compliant with applicable requirements (e.g., facility registration and prior notice), creating spoilage/quality-loss risk for a niche fresh fruit with limited distribution flexibility.Use a compliance checklist covering FDA prior notice and applicable facility registration/FSVP responsibilities; ensure entry data and documentation are accurate before arrival.
Logistics MediumInspection holds and any required phytosanitary treatment coordination can extend dwell time at ports, increasing the likelihood of quality deterioration and commercial loss for small, specialty fresh-fruit consignments.Build buffer time into arrival windows, use experienced produce customs brokerage, and pre-arrange any required APHIS treatment facility movements and safeguarding to avoid unplanned delays.
FAQ
What is the first step to confirm if fresh lucuma can be imported into the United States from a specific origin?Check USDA-APHIS’s Agricultural Commodity Import Requirements (ACIR) database for commodity- and origin-specific admissibility and required phytosanitary measures. If the commodity/origin is not authorized, APHIS describes a commodity import approval process that must be initiated via the exporting country’s NPPO.
Why is phytosanitary clearance a deal-breaker risk for fresh lucuma entering the U.S. market?Because APHIS only authorizes fresh fruits and vegetables when quarantine pest risks can be mitigated under specified conditions, and lucuma is listed as a host for the Mediterranean fruit fly (Ceratitis capitata). That host status commonly triggers strict import measures and treatment/inspection requirements that can block entry if not satisfied.
What U.S. food-import requirements apply in addition to plant health rules for fresh lucuma?FDA states importers are responsible for ensuring imported foods are safe, sanitary, and properly labeled, and that (as applicable) food facility registration and prior notice are required for imports. FDA may inspect and detain shipments offered for import if they are not in compliance.